Follow-The-Filings

Security

RCUS

Arcus Biosciences Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

9 owners 2 exits max 0.1% (Marshall Wace - Marshall ...)

grid → activity →
owners 9
max % 0.1%
tracked value $370M
qoq A 7 R 1 E 2

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.1% Add +0.01 pp 3,761,437 $81M hist
Ken Fisher - Fisher Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 2,190,404 $47M hist
Renaissance Technologies LLC 2026 Q1 0.0% Add +0.01 pp 424,700 $9M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 7,962,874 $190M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 1,329,935 $29M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Add 0.00 pp 259,400 $6M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 139,631 $3M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Reduce -0.08 pp 129,273 $3M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 86,294 $2M hist
Dmitry Balyasny - Balyasny Asset Management L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit -0.02 pp 815,561 $19M hist
Israel Englander - Millennium Management LLC exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 168,876 $4M hist

9 current · 2 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $117M $51M $33M
Gross profit — — —
Gross margin — — —
Net income -$307M -$283M -$353M
Net margin * -262.4% -554.9% -1069.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $831M $1.02B $1.01B
Total non-current assets * $264M $134M $132M
Total assets $1.1B $1.15B $1.14B
Total current liabilities $184M $226M $231M
Total non-current liabilities — — —
Total equity $462M $485M $631M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$306M -$170M -$482M
Cash from investing $194M -$84M $66M
Cash from financing $33M $277M $488M
Net change in cash -$79M $23M $72M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders